Extended-spectrum beta-lactamase-producing E. Coli and Klebsiella Pneumoniae in children at University Pediatric Clinic in Skopje

Macedonian Journal of Medical Sciences

Volumn 2, Issue 1, 2009, Pages 36-41

  Kaftandzhieva, Ana ^a   Kotevska, Vesna ^a   Jankoska, Gordana ^a   Kjurcik Trajkovska, Biljana ^a   Cekovska, Zhaklina ^a   Petrovska, Milena ^a  

^a SS CYRIL AND METHODIUS UNIVERSITY OF SKOPJE   (Macedonia)

Author keywords

Antibiotic susceptibility; ESBL producing Klebsiella pneumoniae; Extended spectrum lactamase producing Escherichia coli

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMOXICILLIN PLUS CLAVULANIC ACID; CEFEPIME; CEFIXIME; CEFPODOXIME; CEFTRIAXONE; CEFUROXIME; CIPROFLOXACIN; CLAVULANIC ACID; COTRIMOXAZOLE; EXTENDED SPECTRUM BETA LACTAMASE; GENTAMICIN; IMIPENEM; NITROFURANTOIN; NORFLOXACIN; OFLOXACIN; PIPEMIDIC ACID; PIPERACILLIN;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL STRAIN; BACTERIUM ISOLATION; CHILD; CHILD HOSPITALIZATION; CONTROLLED STUDY; DISK DIFFUSION; ENZYME SYNTHESIS; ESCHERICHIA COLI; HUMAN; IN VITRO STUDY; KLEBSIELLA PNEUMONIAE; MAJOR CLINICAL STUDY; NONHUMAN; PEDIATRIC HOSPITAL; PHENOTYPE; RESPIRATORY SYSTEM; URINE CULTURE;

EID: 77957731623     PISSN: 18575749     EISSN: 18575773     Source Type: Journal    
DOI: 10.3889/MJMS.1857-5773.2009.0030     Document Type: Article

References (15)

1. Bradford PA. Extended-spectrum β-lactamases in 21st century: characterization, epidemiology, and detection of this important resistance threat. Clinical Microbial Reviews. 2001;14(4):933-951. doi:10.1128/CMR.14.4.933-951.2001
2. Al-Jasser AM. Extended-spectrum beta lactamases (ESBLs): A global problem. Kuwait Medical Journal. 2006; 38 (3):171-185.
3. Rahal JJ. Extended-spectrum β-lactamases: How big is the problem? Clin Microbiol Infect. 2000;6(Suppl 2):2-6.
4. Gniadkowski M. Evolution and epidemiology of extended-spectrum β-lactamases (ESBLs) and ESBL-producing microorganisms. Clin Microbiol Infect. 2001;7(11):597-608.
5. Nathisuwan S, Burgess SD, Lewis SJ. Extended-spectrum-lactamases: epidemiology, detection and treatment. Pharmacotherapy. 2001;21(8):920-928. doi:10.1592/phco.21.11.920.34529
6. Stürenburg E, Mack D. Extended-spectrum β-lactamases: implications for the clinical microbiology laboratory, therapy and infection control. J Infect. 2003;47(4):273-295. doi:10.1016 /S0163-4453(03)00096-3
7. Winokur PL, Canton R, Casellas JM, Legakis N. Variations in the prevalence of strains expressing an extended-spectrum β-lactamase phenotype and characterization of isolates from Europe, the Americas, and the Western Pacific Region. Clin Infect Dis. 2001;32 (Suppl 2):S94-103. doi:10.1086/320182
8. Babini GS, Livermore DM. Antimicrobial resistance amongst Klebsiella spp. Collected from intensive care units in Southern and Western Europe in 1997-1998. J Antimicrob Chemother. 2000;45(2):183-189. doi:10.1093/jac/45.2.183
9. Canton R, Novais A, Valverde A, Machado E, Peixe L, Baquero F, Coque TM. Prevalence and spread of extended-spectrum β-lactamase-producing Enterobacteriaceae in Europe. Clin Microbiol Infect. 2008; 14(Suppl. 1):144-153. doi:10.1111/j.1469-0691.2007.01850.x
10. Lautenbach E, Patel JB, Bilker WB, Edelstein PH, Fishman NO. Extended-spectrum β-lactamase producing Escherichia coli and Klebsiella pneumoniae: Risk factors for infection and impact of resistance on outcomes. Clin Infect Dis. 2001;32:1162-71.
11. Rahman MM, Haq JA, Hossain MA, Sultana R, Islam F, Islam AH. Prevalence of extended-spectrum β-lactamase producing Escherichia coli and Klebsiella pneumoniae in an urban hospital in Dhaka, Bangladesh. Int J Antimicrob Agents. 2004;24(5):508-510. doi:10.1016/ j.ijantimicag.2004.05.007
12. Yu WL, Chuang YC, Walter-Rasmussen J. Extended-spectrum beta-lactamases in Taiwan: Epidemiology, detection, tgreatment and infection control. J Microbiol Immunol Infect. 2006;39(4):264-77.
13. Chaikittisuk N, Munsrichoom A. Extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae in children at Queen Sikirit National Institute of child health. J Infect Dis Antimicrob Agents. 2007; 24(3):107-115.
14. Paterson DL, Bonomo RA. Extended-spectrum β-lactamases: A clinical update. Clinical Microbiolgy Reviews. 2005;18(4):657-686. doi:10.1128/ CMR.18.4.657-686.2005
15. Liao CH, Sheng WH, Wang JT et al. In vitro activities of three antimicrobial agents against ESBL-producing Escherichia coli and Klebsiella pneumoniae in two regional hospitals in Taiwan. J Microbiol Immunol Infect. 2006; 39(1):59-66. doi:10.1007/ 3-540-32952-8_1